Check out our DB stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Regeneron has agreed a $109 million deal to acquire Decibel Therapeutics and its early-stage gene therapy for a form of congenital deafness, several years after forming a partnership to tackle ...